查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1931265

鼻十二指腸餵食管市場依產品類型、最終用戶、應用、通路及置入技術分類，全球預測，2026-2032年

Nasoduodenal Feeding Tube Market by Product Type, End User, Application, Distribution Channel, Placement Technique - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年鼻十二指腸餵食管市場價值為 8.2588 億美元，預計到 2026 年將成長至 8.7176 億美元，到 2032 年將達到 12.8582 億美元，複合年成長率為 6.52%。

關鍵市場統計數據
基準年 2025 8.2588億美元
預計年份：2026年 8.7176億美元
預測年份 2032 12.8582億美元
複合年成長率 (%) 6.52%

本文清楚概述了在急性期、門診和居家照護環境中，鼻十二指腸餵食管置入的臨床意義和操作促進因素。

鼻十二指腸營養管在急性臨床護理和長期營養支持之間起著至關重要的作用，它為臨床醫生提供了一種微創途徑，可以將經腸營養輸送到胃以外的近端小腸。其重要性體現在多個方面，包括重症加護病房（用於控制誤嚥風險）、需要幽門後營養的胃腸道疾病治療方案，以及需要長期支持的門診和居家醫療環境。近年來，該醫療設備領域不僅在材質和內徑方面取得了進步，而且在留置技術和輔助技術方面也取得了顯著進展，旨在提高首次置入成功率並減少手術相關併發症。

留置技術的進步、材料創新以及不斷變化的醫療服務模式如何重新定義臨床工作流程和採購重點

鼻十二指腸餵食管領域正經歷著變革性的轉變，這主要得益於技術進步和醫療服務模式的演變。留置技術的創新，特別是電磁導引系統，正在減少對輻射的依賴並縮短手術時間，進而影響導管的置入位置和方式。同時，聚氨酯和矽膠配方等材料科學的進步提高了導管的柔軟性、生物相容性和患者舒適度，進一步推動了基於臨床場景和內徑要求的產品差異化需求。

檢驗近期貿易措施和關稅調整如何重塑整個價值鏈的籌資策略、供應商合作和採購韌性。

2025年實施的政策調整和關稅措施為鼻十二指腸飼管及相關配件的採購計算引入了新的變數。針對醫療設備零件的進口關稅提高和貿易措施，使得供應鏈依賴性更加清晰可見，促使供應商和經銷商重新評估其籌資策略和供應商關係。因此，採購團隊優先考慮具有垂直整合製造結構和地理分散的供應商，以降低關稅風險和潛在的交貨延遲。

多面向細分分析揭示了產品材料、臨床應用、終端用戶環境、通路和留置技術如何相互作用，從而推動產品採納。

深入的細分分析闡明了產品屬性、終端用戶環境、臨床適應症、分銷管道和留置技術如何相互作用，從而決定設備的採用率和操作適用性。根據產品類型，設備分為聚氨酯和矽膠兩大類，每類又進一步細分為大口徑和小口徑設計，以滿足不同的臨床需求，例如Bolus流速和抗阻塞性。這種材料與口徑的組合會影響臨床醫生在胃動力、導管耐用性和患者舒適度等相互衝突的考慮因素中的選擇。

監管差異、報銷模式和生產能力正在美洲、歐洲、中東和非洲以及亞太地區形成不同的採用路徑。

在美洲、歐洲、中東和非洲以及亞太地區，區域特徵持續影響著鼻十二指腸營養管的臨床實踐、監管要求和供應鏈結構。在美洲，醫療保健系統優先考慮快速的手術流程和居家照護整合，這減少了對放射定位的依賴，並推動了支持門診營養管理技術的應用。該地區的法規結構和支付方趨勢強調可證實的臨床結果和成本效益，從而推動採購能夠最大限度減少併發症和再入院的產品。

主要企業的策略性措施和差異化優勢凸顯了臨床證據、服務組合和經銷夥伴，這些因素共同塑造了它們的競爭優勢。

鼻十二指腸餵食管領域的主要企業正日益將競爭範圍擴展到設備本身之外，更加重視整合式置管解決方案，包括配套服務、臨床醫生培訓、軟硬體指導和操作支援。競爭優勢通常源於可驗證的臨床療效、全面的置管技術培訓項目，以及為門診病人和居家照護客戶提供可靠的物流和售後支援的能力。那些致力於累積臨床證據並與關鍵意見領袖 (KOL) 合作的企業，往往更容易在醫院系統和專科診療路徑中獲得認可。

為製造商、經銷商和供應商提供切實可行的策略，以增強供應鏈韌性、加速臨床應用並實現商業性差異化。

產業領導者應採取平衡策略，同時實現供應鏈韌性、臨床應用和商業性差異化。首先，應優先考慮供應商多元化和合約條款，以降低關稅風險並確保供應連續性。這包括評估區域製造方案，並制定緊急庫存策略以保護大宗客戶。其次，應投資於輔助植入技術和臨床醫生培訓項目，以縮短手術時間和降低併發症率，從而增強對醫院、門診手術中心和居家醫療機構的價值提案。

一項綜合性的多方法研究途徑，結合了臨床訪談、監管整合和供應鏈分析，可提供檢驗的、可操作的見解。

本報告的研究採用多方法綜合考量，結合關鍵相關人員訪談、臨床文獻、監管資料庫和營運供應鏈分析，以確保結論的穩健性和平衡性。研究人員對重症監護、胃腸病和家庭護理領域的臨床醫生、醫院和門診中心的採購負責人以及製造和分銷公司的高管進行了定性訪談。這些訪談深入觀點了留置技術偏好、採購限制以及上市後支援的期望。

全面審視臨床創新、供應鏈韌性和商業性可行性之間至關重要的相互作用，這些因素將決定未來的市場領導地位。

當代鼻十二指腸飼管市場呈現出臨床創新、供應鏈脆弱性和護理模式變革交織的特點，這些因素共同為相關人員帶來了挑戰和機會。留置技術和材料科學的進步正在提高手術效率和病患體驗。同時，關稅壓力和區域監管差異迫使企業重新思考籌資策略和打入市場策略。透過將產品開發與特定的臨床應用和終端用戶需求相結合，企業可以透過差異化產品和服務導向模式創造價值。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的鼻十二指腸餵食管市場

  • 聚氨酯
  • 矽酮

第9章 依最終使用者分類的鼻十二指腸餵食管市場

  • 門診手術中心
  • 居家醫療環境
  • 醫院

第10章 依應用分類的鼻十二指腸餵食管市場

  • 成人營養管理
  • 老年人管飼
  • 兒童營養管理

第11章 依分銷管道分類的鼻十二指腸飼管市場

  • 離線
  • 線上

12. 依置入技術分類的鼻十二指腸餵食管市場

  • 電磁感應
  • 內視鏡
  • 看法

第13章 鼻十二指腸飼管市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 鼻十二指腸餵食管市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國鼻十二指腸飼管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國鼻十二指腸飼管市場

17. 中國：鼻十二指腸飼管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Amsino International Inc.
  • Angiplast Pvt. Ltd.
  • Applied Medical Technology（AMT）, Inc.
  • Avanos Medical, Inc.（formerly Halyard Health）
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company（BD）
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Fresenius Kabi AG
  • GBUK Group
  • Medela AG
  • Medline Industries, Inc.
  • Moog, Inc.
  • Nestle SA/Nestle Health Science
  • Poly Medicure Ltd.
  • Romsons Group
  • Smiths Medical
  • Vygon SA
Product Code: MRR-7B550E008DF5

The Nasoduodenal Feeding Tube Market was valued at USD 825.88 million in 2025 and is projected to grow to USD 871.76 million in 2026, with a CAGR of 6.52%, reaching USD 1,285.82 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 825.88 million
Estimated Year [2026] USD 871.76 million
Forecast Year [2032] USD 1,285.82 million
CAGR (%) 6.52%

A clear overview of clinical importance and operational drivers shaping nasoduodenal feeding tube adoption across acute, ambulatory, and homecare settings

Nasoduodenal feeding tubes occupy a critical intersection between acute clinical care and long-term nutritional support, providing clinicians with a minimally invasive route to deliver enteral nutrition beyond the stomach into the proximal small intestine. Their relevance spans intensive care units managing aspiration risk, gastroenterology pathways requiring post-pyloric feeding, and ambulatory or homecare settings where prolonged support is necessary. In recent years, the device landscape has evolved not only around tube materials and bore sizes but also through improvements in placement techniques and adjunct technologies that aim to improve first-attempt success rates and reduce procedure-related complications.

Despite being a mature category in clinical practice, nasoduodenal feeding tubes continue to be influenced by shifting care models, heightened emphasis on infection prevention, and the need for cost-efficient supply chains. Clinicians prioritize devices that balance patient comfort, luminal patency, and compatibility with placement modalities, while procurement professionals weigh durability, disposability, and supplier reliability. Emerging preferences for outpatient and home-based nutrition management further complicate stakeholder needs, as devices must be both clinically robust and operationally convenient for non-hospital caregivers.

Given these cross-cutting demands, a nuanced understanding of product types, placement techniques, and end-user pathways is essential for stakeholders seeking to invest, innovate, or procure with confidence. This report's introductory perspective frames the clinical imperatives and operational constraints that will shape adoption and procurement decisions across care settings going forward.

How advances in placement technologies, material innovations, and shifting care delivery models are redefining clinical workflows and procurement priorities

The nasoduodenal feeding tube landscape is undergoing transformative shifts driven by both technological advancements and evolving care delivery models. Innovations in placement technologies, particularly electromagnetic guidance systems, are reducing reliance on radiologic resources and shortening procedure times, which in turn influence where and how tubes are placed. Simultaneously, material science refinements in polyurethane and silicone formulations have improved flexibility, biocompatibility, and patient comfort, reinforcing the need for product differentiation based on clinical scenarios and bore size requirements.

Beyond device-level innovation, broader health system trends are shifting demand patterns. Hospitals are optimizing care pathways to reduce length of stay, creating greater demand for reliable post-acute feeding solutions that can be managed in homecare settings. Ambulatory surgical centers are increasingly performing procedures that previously required inpatient admission, prompting a rethink of device procurement and logistics to support same-day or short-stay placements. Meanwhile, telehealth and remote monitoring solutions are enhancing clinician oversight of enteral nutrition regimens, permitting more conservative in-person visitation without compromising safety.

Supply chain resilience and regulatory focus on patient safety are additional vectors of change. Providers and suppliers are prioritizing traceability, sterility assurance, and training programs to reduce procedural complications and readmissions. Taken together, these shifts underscore a market that rewards integrated solutions combining advances in placement technique, material innovation, and service-oriented distribution to meet the needs of an increasingly decentralized continuum of care.

Examining how recent trade measures and tariff adjustments are reshaping sourcing strategies, supplier alignment, and procurement resilience across the value chain

Policy shifts and tariff measures enacted in 2025 have introduced new variables into the procurement calculus for nasoduodenal feeding tubes and related accessories. Increased import duties and trade measures targeting medical device components have raised the visibility of supply chain dependencies, prompting providers and distributors to reassess sourcing strategies and supplier relationships. As a result, procurement teams are prioritizing suppliers with vertically integrated manufacturing or diversified geographic footprints to mitigate tariff exposure and potential delivery disruptions.

These trade interventions have also accelerated conversations about nearshoring and onshoring of critical device components. Manufacturers are evaluating the economic trade-offs between reconfiguring production closer to end markets and maintaining globalized sourcing that benefits from scale economies. In parallel, distributors and hospital purchasing groups are renegotiating contract terms to allocate tariff-related cost fluctuations and are exploring hedging mechanisms such as longer-term agreements or supplier consignment models. Payment and reimbursement stakeholders are increasingly attentive to cost transparency, which affects purchasing decisions for hospitals, ambulatory centers, and homecare providers.

For emerging and mid-sized suppliers, tariff pressures can create both challenge and opportunity. Some firms face compressed margins and must innovate in packaging, logistics, or service offerings to remain competitive, while others leverage tariff-driven market dislocations to win contracts by demonstrating supply chain robustness. Ultimately, the cumulative effect of 2025 tariff measures has heightened the premium on supply-chain intelligence, contractual agility, and strategic manufacturing location decisions across the value chain.

A multifaceted segmentation perspective revealing how product materials, clinical applications, end-user settings, distribution channels, and placement techniques interact to drive adoption

Insightful segmentation analysis clarifies how product attributes, end-user environments, clinical indications, distribution choices, and placement techniques interact to determine device adoption and operational fit. Based on product type, devices are distinguished between polyurethane and silicone materials, each of which may be further differentiated by large bore and small bore designs that address distinct clinical needs such as bolus flow rates versus clog resistance. This material and bore matrix informs clinician preferences where gastric motility, tube longevity, and patient comfort are competing priorities.

Based on end user, clinical and operational requirements diverge among ambulatory surgical centers, homecare settings, and hospitals. Ambulatory surgical centers prioritize devices that support efficient throughput and same-day procedures, hospitals focus on integration with intra-hospital care pathways and compatibility with multiple placement modalities, while homecare settings demand simplicity, caregiver-friendly features, and robust support services. Based on application, patient population nuances across adult feeding, geriatric feeding, and pediatric feeding necessitate tailored designs and portfolio segmentation, as anatomical variability and tolerance thresholds differ substantially among these cohorts.

Based on distribution channel, purchasing patterns vary from direct tender agreements and hospital pharmacy procurement to the growing influence of online store channels and traditional retail pharmacy access for outpatient needs; each pathway imposes distinct requirements around packaging, education, and regulatory compliance. Finally, based on placement technique, the relative uptake of electromagnetic guidance, endoscopic placement, and fluoroscopic methods influences device compatibility requirements, training investments, and capital equipment needs. Recognizing how these segmentation axes intersect enables stakeholders to design product portfolios and commercial strategies that are tightly aligned with clinical workflows and procurement mechanisms.

How regulatory diversity, reimbursement models, and manufacturing capabilities are creating distinct adoption pathways across the Americas, EMEA, and Asia-Pacific regions

Regional nuances continue to shape clinical practice, regulatory expectations, and supply chain architecture for nasoduodenal feeding tubes across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, healthcare systems often prioritize rapid procedural workflows and homecare integration, which has incentivized adoption of technologies that reduce dependence on radiologic placement and support outpatient feeding management. Regulatory frameworks and payer dynamics in this region place emphasis on demonstrable clinical outcomes and cost-effectiveness, driving procurement toward products that minimize complications and readmissions.

In Europe, Middle East & Africa, heterogeneity in regulatory regimes and healthcare funding models creates a mosaic of adoption pathways. Several markets within this region emphasize stringent device quality standards and post-market surveillance, making supplier compliance and robust clinical evidence critical for market access. Reimbursement policies can vary not only by country but by care setting, which influences whether hospitals, ambulatory centers, or homecare providers lead procurement decisions. Across the EMEA region, there is also heightened interest in device sustainability and lifecycle management.

Asia-Pacific encompasses diverse market maturities, with advanced healthcare systems rapidly adopting minimally invasive placement technologies and an expanding base of homecare services in urban centers. At the same time, manufacturing capacity in parts of the region contributes to competitive supply dynamics and innovation in cost-efficient materials and production techniques. Stakeholders operating in Asia-Pacific must navigate a spectrum of regulatory pathways and payer arrangements while leveraging local manufacturing and distribution strengths to serve both domestic and export markets.

Strategic moves and differentiators among leading firms highlighting clinical evidence, service bundles, and distribution partnerships that shape competitive advantage

Leading firms in the nasoduodenal feeding tube arena are increasingly competing beyond the device itself, emphasizing bundled services, clinician education, and integrated placement solutions that combine hardware with software-enabled guidance or procedural support. Competitive differentiation often stems from demonstrable clinical outcomes, comprehensive training programs for placement techniques, and the ability to offer reliable logistics and post-sale support for outpatient and homecare customers. Companies that invest in clinical evidence generation and KOL engagement tend to secure stronger traction within hospital systems and specialty care pathways.

Strategic partnerships between device manufacturers and distributors are reshaping market access. Distributors with deep hospital relationships can accelerate adoption by offering product training and inventory management, while manufacturers that invest in digital tools to support remote monitoring or placement guidance can create stickier customer relationships. Additionally, some companies pursue targeted M&A or licensing arrangements to broaden their portfolios across material types, bore sizes, or placement-adjacent technologies, enabling cross-selling into multiple end-user segments.

Smaller and mid-sized suppliers often seek niche leadership by focusing on particular patient populations or placement techniques, while larger incumbents leverage scale to provide bundled procurement solutions and global after-sales service. Across the competitive spectrum, success increasingly depends on the ability to align product development with clinical workflow optimization and to demonstrate measurable improvements in procedural efficiency and patient outcomes.

Actionable strategies for manufacturers, distributors, and providers to strengthen supply resilience, accelerate clinical adoption, and differentiate commercial offerings

Industry leaders should pursue a balanced strategy that addresses supply chain resilience, clinical adoption, and commercial differentiation simultaneously. First, prioritize supplier diversification and contractual terms that mitigate tariff risk and ensure continuity of supply; this includes evaluating regional manufacturing options and developing contingency stock strategies to protect high-volume clients. Second, invest in placement-support technologies and clinician training programs that reduce procedure time and complication rates, thereby enhancing the value proposition to hospitals, ambulatory surgical centers, and homecare providers.

Third, refine product portfolios to reflect clear clinical segmentation by material and bore size, targeting adult, geriatric, and pediatric indications with evidence-backed device choices that demonstrate improved tolerance and longevity. Fourth, optimize distribution channel mix by aligning direct tender and hospital pharmacy strategies with online and retail access points for outpatient care, ensuring packaging and educational materials are tailored to non-clinician caregivers. Fifth, engage proactively with payers and procurement committees to articulate the total cost of care benefits associated with improved placement success and reduced adverse events.

Finally, commit to measurable sustainability and quality initiatives, including sterilization and waste-reduction practices, which can be leveraged in both procurement negotiations and brand positioning. Taken together, these actions will help organizations convert insight into competitive execution while navigating regulatory, tariff, and clinical practice headwinds.

A comprehensive multi-method research approach combining clinical interviews, regulatory synthesis, and supply chain analysis to deliver validated, actionable insights

The research underpinning this report follows a multi-method approach that triangulates primary stakeholder interviews, clinical literature, regulatory databases, and operational supply chain analysis to ensure robust and balanced insights. Primary qualitative interviews were conducted with clinicians across intensive care, gastroenterology, and homecare nursing, procurement officers from hospitals and ambulatory centers, and senior executives at manufacturing and distribution firms. These conversations provided real-world perspectives on placement technique preferences, procurement constraints, and post-market support expectations.

Secondary sources included peer-reviewed clinical studies, professional society guidelines, device labeling and regulatory filings, and public statements from industry participants, which were synthesized to contextualize clinical efficacy and safety considerations. Supply chain mapping employed import-export data, logistics pathway review, and supplier footprint analysis to assess risks associated with tariffs and geographic concentration. Findings were validated through expert panel reviews and cross-checked for consistency against multiple independent data points.

Limitations of the methodology are acknowledged, including variability in regional reporting standards and the evolving nature of tariff and policy environments. Nevertheless, the combined qualitative and documentary approach ensures that conclusions are grounded in practical clinical experience and verifiable public information, providing actionable insight for decision-makers.

Concluding perspective on the critical interplay between clinical innovation, supply resilience, and commercial execution that will determine future market leadership

The contemporary nasoduodenal feeding tube landscape is defined by a convergence of clinical innovation, supply chain sensitivity, and shifting care models that together create both challenges and opportunities for stakeholders. Advances in placement technology and material science are improving procedural efficiency and patient experience, while tariff-related pressures and regional regulatory diversity are compelling organizations to rethink sourcing and market entry strategies. By aligning product development with specific clinical applications and end-user needs, companies can capture value through differentiated offerings and service-oriented models.

Operationally, success will depend on an organization's ability to integrate clinical evidence generation, robust training, and flexible distribution strategies. Stakeholders that proactively manage supply chain risk, invest in clinician-facing technologies, and tailor commercial approaches to regional and end-user nuances will be best positioned to respond to evolving payer expectations and care delivery trends. The imperative is clear: translate insights into prioritized actions that preserve clinical quality while enhancing operational resilience and commercial viability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nasoduodenal Feeding Tube Market, by Product Type

  • 8.1. Polyurethane
  • 8.2. Silicone

9. Nasoduodenal Feeding Tube Market, by End User

  • 9.1. Ambulatory Surgical Center
  • 9.2. Homecare Setting
  • 9.3. Hospital

10. Nasoduodenal Feeding Tube Market, by Application

  • 10.1. Adult Feeding
  • 10.2. Geriatric Feeding
  • 10.3. Pediatric Feeding

11. Nasoduodenal Feeding Tube Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Nasoduodenal Feeding Tube Market, by Placement Technique

  • 12.1. Electromagnetic Guidance
  • 12.2. Endoscopic
  • 12.3. Fluoroscopic

13. Nasoduodenal Feeding Tube Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Nasoduodenal Feeding Tube Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Nasoduodenal Feeding Tube Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Nasoduodenal Feeding Tube Market

17. China Nasoduodenal Feeding Tube Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Amsino International Inc.
  • 18.6. Angiplast Pvt. Ltd.
  • 18.7. Applied Medical Technology (AMT), Inc.
  • 18.8. Avanos Medical, Inc. (formerly Halyard Health)
  • 18.9. B. Braun Melsungen AG
  • 18.10. Baxter International Inc.
  • 18.11. Becton, Dickinson and Company (BD)
  • 18.12. Boston Scientific Corporation
  • 18.13. Cardinal Health, Inc.
  • 18.14. Cook Medical LLC
  • 18.15. Fresenius Kabi AG
  • 18.16. GBUK Group
  • 18.17. Medela AG
  • 18.18. Medline Industries, Inc.
  • 18.19. Moog, Inc.
  • 18.20. Nestle S.A. / Nestle Health Science
  • 18.21. Poly Medicure Ltd.
  • 18.22. Romsons Group
  • 18.23. Smiths Medical
  • 18.24. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NASODUODENAL FEEDING TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NASODUODENAL FEEDING TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NASODUODENAL FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NASODUODENAL FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY HOMECARE SETTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY HOMECARE SETTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY HOMECARE SETTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ADULT FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ADULT FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ADULT FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY GERIATRIC FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY GERIATRIC FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY GERIATRIC FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY PEDIATRIC FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY PEDIATRIC FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY PEDIATRIC FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ELECTROMAGNETIC GUIDANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ELECTROMAGNETIC GUIDANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ELECTROMAGNETIC GUIDANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY FLUOROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY FLUOROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY FLUOROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS NASODUODENAL FEEDING TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 102. GCC NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. GCC NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. GCC NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. GCC NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 120. G7 NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. G7 NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. G7 NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. G7 NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 126. NATO NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. NATO NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NATO NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. NATO NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NASODUODENAL FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES NASODUODENAL FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA NASODUODENAL FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA NASODUODENAL FEEDING TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA NASODUODENAL FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA NASODUODENAL FEEDING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA NASODUODENAL FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA NASODUODENAL FEEDING TUBE MARKET SIZE, BY PLACEMENT TECHNIQUE, 2018-2032 (USD MILLION)